openPR Logo
Press release

Macrolide Drugs Market Prediction and Analysis Offered By New Study - 2025

12-11-2017 12:12 PM CET | Health & Medicine

Press release from: Transparency Market Research

Macrolide Drugs Market Prediction and Analysis Offered By New

Macrolides is a class of antibacterial drugs that contain a large macrocyclic lactone ring substituted with certain unusual sugars. This class comprises drugs that inhibit protein synthesis in harmful and infectious gram-positive bacteria. These molecules bind to the 50S ribosomal unit, thereby restricting the ribosomes from carrying out the bacterial protein synthesis. Protein synthesis in bacteria is inhibited by macrolide drugs. Macrolide drugs are primarily bacteriostatic; however, they may be bactericidal at high concentrations or depending on the type of bacterial strain. These drugs were first extracted from Streptomyces erythraeus. The drug was named erythromycin back in the 1950s. Two other synthetic derivatives viz. clarithromycin and azithromycin were later developed by utilizing erythromycin in the 1970s and 1980s respectively.

Report Overview and TOC @ https://www.transparencymarketresearch.com/macrolide-drugs-market.html

Macrolides have a broad spectrum of activity and are effective against several bacterial strains of Streptococcus, Clostridium, Corynebacterium, Haemophilus, Listeria, Legionella, Staphylococcus, Mycoplasma sp., and Neisseria meningitidis. Macrolide drugs are active against gram-positive bacteria, as they can easily penetrate the cell walls of gram-positive bacteria. Neither peptidoglycan (present in bacterial cell walls) nor the cytoplasmic membrane act as a barrier to these molecules when they enter the cell walls of gram-positive bacteria. However, macrolides are inactive in case of a gram-negative bacteria, as they are unable to penetrate the cell walls of gram-negative bacteria. This is because the outer membrane of these cells is hydrophilic with aqueous porins and on the other hand, macrolides are lyophilic in nature.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34406

Some of the major antibacterial drugs that belong to the macrolide drug class are erythromycin, clarithromycin, azithromycin, dirithromycin, roxithromycin, troleandomycin, fidaxomicin, and telithromycin. Macrolides accounted for 7.0% share of the global antibacterial drugs industry in 2014. The global macrolide drugs market is anticipated to expand at a moderate rate during the forecast period. Key growth drivers for the market include the increasing prevalence of infectious diseases, growing elderly population, increasing number of multidrug-resistant bacterial strains, and higher benefits over traditional antibiotics. Most developed economies such as the U.S., Japan, and countries of Western Europe have large elderly population that is more prone to various bacterial infections primarily caused by low immunity. Also, macrolides exhibit different characteristics such as good oral absorption, easy absorption in tissues, easier dosage of once or twice a day, and lower incidence of side-effects. These make macrolides more useful that other antibacterial drugs. Also, they can be utilized widely to treat mild-to-moderate bacterial infections. However, in some cases, liver injuries have been observed due to usage of macrolides. This factor along with patent expiries and influx of generic drugs may restrain the market for macrolide drugs during the forecast period.

The global macrolide drugs market can be segmented based on type of drug, distribution channel, and region. Based on type of drug, the market has been divided into drugs such as erythromycin, clarithromycin, azithromycin, dirithromycin, roxithromycin, troleandomycin, fidaxomicin, and telithromycin. Based on distribution channel, the market has been classified into hospital pharmacies, clinics, hospitals, retail pharmacies, and online pharmacies.

Geographically, the global macrolide drugs market can be segmented into five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Rest of World (RoW). Asia Pacific held the leading market share, followed by North America, in 2016. These two regions are expected to retain their positions from 2017 to 2025. Rising prevalence of bacterial infection and increasing government initiatives that appear to be moving toward shorter periods of patent exclusivity for new drug applications are some of the factors driving the market in these regions. Moreover, large population, increasing disposable income, and growing patient awareness are some of the other factors driving the market in Asia Pacific. Europe and Rest of the World are likely to present significant growth opportunities in the macrolide drugs market. This is attributable to increasing geriatric population in these regions, which is more prone to bacterial infections triggered by low immunity.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=33710<ype=S

Key players operating in the global macrolide drugs market are Eli Lilly & Co., Pfizer, Inc., Sanofi, Merck & Co., Inc., Abbott Laboratories, and Akorn, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macrolide Drugs Market Prediction and Analysis Offered By New Study - 2025 here

News-ID: 854378 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Macrolide

Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is
Macrolide Antibiotics Market In-Depth Market Research Report 2018-2026(Macrolide …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is
Macrolide Antibiotics Market Report 2018 - GlaxoSmithKline, Johnson & Johnson, B …
An exclusive Macrolide Antibiotics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Macrolide Antibiotics Market By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Route of Administration (Oral, Parenteral), By Infection (Mycoplasma pneumoniae, Legionella sp., Or Bordetella pertussis,Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis, Uncomplicated Skin Infections), By End User (Hospital,
World Macrolide Antibiotics Market Analysis Latest Report by Major Growth Driver …
New Report on "Worldwide Macrolide Antibiotics Market" added to marketresearchfuture.com database. The Industry Report Provide analysis and assessment of the present profitability. Macrolide Antibiotics Market - Scenario Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections,
Macrolide Antibiotics Market to Reflect Impressive Growth Rate Along with Top Ve …
Market Research Future recently introduced Global Macrolide Antibiotics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The report also provide detail analysis of the market structure along with forecast, market size & share, various segments and growing trends of the bottled water industry. Macrolide antibiotics Market -Highlights Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that
Macrolide Antibiotics Market Surpass 12.5% CAGR by 2023 | Says MarketResearchFut …
The International Macrolide Antibiotics Market is expected to grow at a CAGR of 12.5% during the forecast period from 2018-2023. Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma, and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria,